Molecular NeuroImaging

Molecular Neuro Imaging

Biotechnology, 60 Temple St, New Haven, Connecticut, 06510, United States, 51-200 Employees

mnimaging.com

  • facebook
  • LinkedIn

phone no Phone Number: +16*********

Who is MOLECULAR NEUROIMAGING

Molecular NeuroImaging provides neuroimaging research services to the pharmaceutical and biotech industries. By focusing on developing radioligands as tools for human research, we will im...

Read More

map
  • 60 Temple St, New Haven, Connecticut, 06510, United States Headquarters: 60 Temple St, New Haven, Connecticut, 06510, United States
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 621111 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from MOLECULAR NEUROIMAGING

Molecular NeuroImaging Org Chart and Mapping

Employees

Deborah Stottle

Certified Clinical Research Coordinator

Kristen Scarpa

Technology Support Specialist

Shirley Lasch

Director Project Manager, Clinical Imaging Program Management

Eileen Smith

Director Special Project Development

Ronald B

Director Chemistry Manufacturing & Quality Control

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Molecular NeuroImaging

Answer: Molecular NeuroImaging's headquarters are located at 60 Temple St, New Haven, Connecticut, 06510, United States

Answer: Molecular NeuroImaging's phone number is +16*********

Answer: Molecular NeuroImaging's official website is https://mnimaging.com

Answer: Molecular NeuroImaging's revenue is $25 Million to $50 Million

Answer: Molecular NeuroImaging's SIC: 2834

Answer: Molecular NeuroImaging's NAICS: 621111

Answer: Molecular NeuroImaging has 51-200 employees

Answer: Molecular NeuroImaging is in Biotechnology

Answer: Molecular NeuroImaging contact info: Phone number: +16********* Website: https://mnimaging.com

Answer: Molecular NeuroImaging provides neuroimaging research services to the pharmaceutical and biotech industries. By focusing on developing radioligands as tools for human research, we will improve early diagnosis and rapid drug development for neurodegenerative and neuropsychiatric disorders. MNI key activities: * Radioligand development * Early phase human drug-trials-displacement/occupancy * Large scale Phase II-IV clinical imaging trials. * Multi-center quantitative imaging trials - Clinical imaging site coordination as a technical CRO - Core image processing laboratory * Biomarker development presymptomatic and disease progression.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access